Search Within

Samira Anjum Fatmi

Formats
  1. Meeting Abstract (11)
  2. Journal Article (3)
Groups
  1. Bone Marrow Transplant (14)
  2. CTCR Scholars (14)
  3. Center for Hematologic Malignancies (14)
  4. Department of Medicine (14)
  5. Hematologic Malignancies, Division of (14)
  6. MSK Grad Students (13)

More Groups

People
  1. Doris Ponce (13)
  2. Miguel-Angel Perales (10)
  3. Sergio Giralt (9)
  4. Molly Maloy (7)
  5. Antonio Gomes (5)
  6. Gillian Moore (5)

More People

Years
  1. 2023 (2)
  2. 2020 (2)
  3. 2019 (5)
  4. 2018 (4)
  5. 2017 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (5)
  2. Blood (4)
  3. Bone Marrow Transplantation (4)
  4. Advances in Cell and Gene Therapy (1)
Publishers
  1. Elsevier Inc. (5)
  2. American Society of Hematology (4)
  3. Nature Publishing Group (4)
  4. John Wiley & Sons (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation
    Journal Article

    Sanchez-Escamilla, M.; Flynn, J.; Devlin, S.; Maloy, M.; Fatmi, S. A.; Tomas, A. A.; Escribano-Serrat, S.; Ponce, D.; Sauter, C. S.; Giralt, S. A.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
    Journal Article

    Ponce, D. M.; Alousi, A. M.; Nakamura, R.; Slingerland, J.; Calafiore, M.; Sandhu, K. S.; Barker, J. N.; Devlin, S.; Shia, J.; Giralt, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute lower GI GVHD
    Meeting Abstract

    Ponce, D.; Alousi, A.; Nakamura, R.; Sandhu, K.; Barker, J.; Shia, J.; Yan, X.; Daley, W.; Moore, G.; Fatmi, S.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • A phase 2 study of F-652, a novel tissue-targeted recombinant human interleukin-22 (IL-22) dimer, for treatment of newly diagnosed acute GVHD of the lower GI tract
    Meeting Abstract

    Ponce, D. M.; Alousi, A. M.; Nakamura, R.; Sandhu, K. S.; Barker, J. N.; Shia, J.; Yan, X; Daley, W. L.; Moore, G.; Fatmi, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Establishing a standardized system for review and adjudication of chronic graft-vs-host disease data in accordance with the National Institutes Consensus criteria
    Journal Article

    Dierov, D.; Webb, N.; Fatmi, S.; Nwanne, C.; Ciolino, C.; Mosesso, K.; Nieves, J.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
    Advances in Cell and Gene Therapy (2019)

    Fulltext@MSK | Save
  • The EASIX score is associate with overall survival and non-relapse mortality after ex-vivo CD34(+)-selected allogeneic HCT
    Meeting Abstract

    Sanchez-Escamilla, M.; Hilden, P.; Maloy, M. A.; Fatmi, S.; Giralt, S. A.; Scordo, M.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Pre-transplant and peri-d100 gastrointestinal dysbiosis is associated with the subsequent development of chronic graft-versus-host disease
    Meeting Abstract

    Markey, K. A.; Gomes, A.; Littmann, E.; Devlin, S. M.; Slingerland, A. E.; Moore, G.; Fatmi, S.; Slingerland, J.; Clurman, A.; Maloy, M. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • HLA-a*0101 allele is associated with increased risk of cutaneous acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Fonseca, M.; Jakubowski, A. A.; Devlin, S. M.; Young, J. W.; Fatmi, S.; Maloy, M. A.; Giralt, S. A.; Ponce, D. M.; Markova, A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • EASIX score predicts high-grade acute GVHD, non-relapse mortality, and overall survival in adult patients undergoing unmodified or CD34-selected allogeneic HCT
    Meeting Abstract

    Sanchez-Escamilla, M.; Hilden, P.; Malloy, M.; Ruiz, J. D.; Fatmi, S.; Sauter, C. S.; Ponce, D.; Giralt, S. A.; Scordo, M.; Perales, M. A.
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • The prognostic calculator EASIX predicts acute GVHD, non-relapse mortality and overall survival in adult patients undergoing reduced intensity conditioning allogeneic HCT
    Meeting Abstract

    Sanchez-Escamilla, M.; Hilden, P.; Maloy, M.; Fatmi, S. A.; Ponce, D.; Sauter, C. S.; Giralt, S.; Perales, M. A.
    Blood (2018)

    Fulltext@MSK | Save